TrialDrugs in R&D2024

A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides.

Xiaojie Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.